Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2021
Genelux grants ELIAS Animal Health worldwide exclusive license for V-VET1
Genelux announced an exclusive worldwide licensing agreement with ELIAS Animal Health for V-VET1, granting ELIAS rights to develop and commercialize the veterinary cancer treatment candidate.